SERUM AMYLOID-A (SAA) - BIOCHEMISTRY, GENETICS AND THE PATHOGENESIS OF AA AMYLOIDOSIS

被引:160
作者
HUSBY, G
MARHAUG, G
DOWTON, B
SLETTEN, K
SIPE, JD
机构
[1] UNIV TROMSO HOSP,DEPT PEDIAT,TROMSO,NORWAY
[2] UNIV OSLO,DEPT BIOCHEM,OSLO 3,NORWAY
[3] WASHINGTON UNIV,SCH MED,JAMES S MACDONNELL DEPT GENET,ST LOUIS,MO
[4] BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118
来源
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION | 1994年 / 1卷 / 02期
关键词
AA PROTEIN; AMYLOIDOSIS; SAA GENES; APOSAA PROTEINS; ABBREVIATIONS; AEF; AMYLOID ENHANCING FACTOR;
D O I
10.3109/13506129409148635
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum amyloid A (apoSAA) is a polymorphic protein encoded by a family of SAA genes in which new members continue to be identified. Those isoforms or allelic forms that are precursors for the amyloid fibril protein A(AA) in reactive (secondary) amyloidosis, are among the acute phase or regulated apoSAA apoproteins complexed with high density lipoprotein (HDL); other isoforms are expressed constitutively. The chief function of apoSAA, which is a well conserved protein found in birds and mammals, has probably not yet been disclosed, but is thought to be part of the host response to infections and tissue damage. Structural and functional aspects of apoSAA, and its role in AA amyloidosis are complex due to the presence of multiple isoforms. Most species appear to possess two main acute phase apoSAA isoforms of hepatic origin in their serum (apoSAA(1) and apoSAA(2)) and a third form that has predominant extrahepatic expression (apoSAA(3)). A single constitutive isoform, apoSAA(4), has been identified in human and apoSAA(5) has been described in BALB/c mice. Thus, apoSAA proteins can be regarded or subclassified as either acute phase reactants (regulated apoSAA also termed A-SAA) or constitutive proteins (C-SAA).
引用
收藏
页码:119 / 137
页数:19
相关论文
共 171 条
[1]  
ALDOBENSON MA, 1982, J IMMUNOL, V126, P2390
[2]  
ANDERS RF, 1977, J IMMUNOL, V118, P229
[3]   IDENTIFICATION OF 2 NOVEL AMYLOID-A PROTEIN SUBSETS COEXISTING IN AN INDIVIDUAL PATIENT OF AA-AMYLOIDOSIS [J].
BABA, S ;
TAKAHASHI, T ;
KASAMA, T ;
SHIRASAWA, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1180 (02) :195-200
[4]  
BADALATO R, 1993, J IMMUNOL, V150, pA217
[5]   ACUTE-PHASE HIGH-DENSITY-LIPOPROTEIN IN THE RAT DOES NOT CONTAIN SERUM AMYLOID A-PROTEIN [J].
BALTZ, ML ;
ROWE, IF ;
CASPI, D ;
TURNELL, WG ;
PEPYS, MB .
BIOCHEMICAL JOURNAL, 1987, 242 (01) :301-303
[6]  
BAUMANN H, 1990, MOL BIOL MED, V7, P147
[7]   NH2-TERMINAL ANALYSIS OF 4 OF THE POLYMORPHIC FORMS OF HUMAN-SERUM AMYLOID A PROTEINS [J].
BAUSSERMAN, LL ;
SARITELLI, AL ;
HERBERT, PN ;
MCADAM, KPWJ ;
SHULMAN, RS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 704 (03) :556-559
[8]  
BAUSSERMAN LL, 1987, J BIOL CHEM, V262, P1583
[9]   TIME COURSE OF SERUM AMYLOID-A RESPONSE IN MYOCARDIAL-INFARCTION [J].
BAUSSERMAN, LL ;
SADANIANTZ, A ;
SARITELLI, AL ;
MARTIN, VL ;
NUGENT, AM ;
SADY, SP ;
HERBERT, PN .
CLINICA CHIMICA ACTA, 1989, 184 (03) :297-306
[10]   HETEROGENEITY OF HUMAN-SERUM AMYLOID A PROTEINS [J].
BAUSSERMAN, LL ;
HERBERT, PN ;
MCADAM, KPWJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (03) :641-656